Verification evidence is still being completed.
PDF / print export
RHEACELL
Heidelberg, Germany
- Verified lead
- Dr. Christoph Ganss
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Physician, Chief Executive Officer and Founder
- 2026 technical specialization
- Regenerative Medicine, Stromal Cell Therapy, Advanced Therapeutics, and Cell-Based Clinical Development
- Review cycle
- May 2026
- Full address
- Im Neuenheimer Feld 517, 69120 Heidelberg, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- RHEACELL team disclosure.
- Editorial note
- Regenerative-medicine node positioned around stromal-cell therapeutics, clinical execution, and Heidelberg cluster translation.
Regenerative Medicine, Stromal Cell Therapy, Advanced Therapeutics, and Cell-Based Clinical Development
Cell-therapy development quality systems, Clinical-stage regenerative-medicine controls
Regenerative-medicine node positioned around stromal-cell therapeutics, clinical execution, and Heidelberg cluster translation.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated05 Jun 2026, 01:06
Company profile · Heidelberg, Germany
RHEACELL
Regenerative Medicine, Stromal Cell Therapy, Advanced Therapeutics, and Cell-Based Clinical Development · Clinical-stage regenerative-medicine platform
Verified 15 Mar 2026 · 3 sources
Cell TherapyClinical
Regenerative-medicine node positioned around stromal-cell therapeutics, clinical execution, and Heidelberg cluster translation.
Contact & location
- Website
- rheacell.com
- Company page
- Lead
- Dr. Christoph Ganss (verified ↗)
- Compliance
- GMP · GLP
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- Clinical-stage regenerative-medicine platform
- Capabilities
- Cell-therapy platform development · Regenerative medicine · Clinical product development
- Founded
- 2003
- Headcount
- 51-200
Clinical profileSTATUS: VERIFIED MARCH 2026
Dr. Christoph Ganss
Physician, Chief Executive Officer and Founder
Full addressIm Neuenheimer Feld 517, 69120 Heidelberg, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official RHEACELL contact page naming Im Neuenheimer Feld 517, Heidelberg as the company address.
Open sourceClinical-stage regenerative-medicine platform
Heidelberg, Germany. Regenerative Medicine, Stromal Cell Therapy, Advanced Therapeutics, and Cell-Based Clinical Development. Review completed on 15 Mar 2026.
German and EU advanced-therapy medicinal-products framework
Cell-therapy development quality systems, Clinical-stage regenerative-medicine controls
Regenerative Medicine, Stromal Cell Therapy, Advanced Therapeutics, and Cell-Based Clinical Development
Regenerative-medicine node positioned around stromal-cell therapeutics, clinical execution, and Heidelberg cluster translation.
Related companies
Editorial note
RHEACELL gives the Heidelberg layer a regenerative-medicine node with public executive leadership and clinically relevant cell-therapy positioning.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Cell-therapy platform development
Regenerative medicine
Clinical product development
ATMP programme execution
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Cell-therapy platform laboratories
Regenerative-medicine process workflows
Clinical development systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
Verification history
Verification history
15 Mar 2026: Executive identity confirmed via official management disclosure.
15 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is RHEACELL located?
- RHEACELL operates from Im Neuenheimer Feld 517, 69120 Heidelberg, Germany, Heidelberg, Germany.
- Who runs RHEACELL?
- RHEACELL is led by Dr. Christoph Ganss, Physician, Chief Executive Officer and Founder. Verified 15 Mar 2026.
- What does RHEACELL do?
- Regenerative-medicine node positioned around stromal-cell therapeutics, clinical execution, and Heidelberg cluster translation. Core capabilities: Cell-therapy platform development, Regenerative medicine, Clinical product development, ATMP programme execution.
Editorial context
Related technical briefs
Briefs that name Heidelberg as a covered market or city.